Why Tilray's Marijuana Rescheduling Sizzle Has Fizzled
Marijuana stocks experienced a short-lived surge back on April 22. Tilray Brands (NASDAQ: TLRY) was no exception.
The boost was triggered by news of the Department of Justice's plans to reschedule regulated marijuana products from Schedule I to Schedule III of the Controlled Substances Act.
However, soon after this rally took shape, these same stocks coughed back their gains, and then some. After surging from around $7 to around $8 per share in a matter of hours, Tilray stock dropped closer to $6.
Source Fool.com
